Online citations, reference lists, and bibliographies.

A Multimodal Imaging Approach For Longitudinal Evaluation Of Bladder Tumor Development In An Orthotopic Murine Model

Chantal Scheepbouwer, Sandra Meyer, Maroeska J Burggraaf, Jithin Jose, Carla F. M. Molthoff
Published 2016 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Bladder cancer is the fourth most common malignancy amongst men in Western industrialized countries with an initial response rate of 70% for the non-muscle invasive type, and improving therapy efficacy is highly needed. For this, an appropriate, reliable animal model is essential to gain insight into mechanisms of tumor growth for use in response monitoring of (new) agents. Several animal models have been described in previous studies, but so far success has been hampered due to the absence of imaging methods to follow tumor growth non-invasively over time. Recent developments of multimodal imaging methods for use in animal research have substantially strengthened these options of in vivo visualization of tumor growth. In the present study, a multimodal imaging approach was addressed to investigate bladder tumor proliferation longitudinally. The complementary abilities of Bioluminescence, High Resolution Ultrasound and Photo-acoustic Imaging permit a better understanding of bladder tumor development. Hybrid imaging modalities allow the integration of individual strengths to enable sensitive and improved quantification and understanding of tumor biology, and ultimately, can aid in the discovery and development of new therapeutics.
This paper references
10.1364/OL.36.004815
Evaluation of bladder microvasculature with high-resolution photoacoustic imaging.
Zhixing Xie (2011)
10.1002/ijc.2910490623
Extensive multi-organ metastasis following orthotopic onplantation of histologically-intact human bladder carcinoma tissue in nude mice.
X Y Fu (1991)
10.1002/cncr.28905
Novel endoscopic diagnosis for bladder cancer.
Seth P. Lerner (2015)
10.1016/j.molmed.2012.01.005
Bioluminescence imaging: looking beyond the light.
Marleen Keyaerts (2012)
10.1007/s00259-008-1022-8
Comparison of subcutaneous and intraperitoneal injection of d-luciferin for in vivo bioluminescence imaging
Yusuke Inoue (2008)
10.1038/sj.cgt.7700489
Visualizing superficial human bladder cancer cell growth in vivo by green fluorescent protein expression
Jain-Hua Zhou (2002)
10.7863/ultra.32.7.1245
Photoacoustic imaging of the bladder: a pilot study.
Aya Kamaya (2013)
10.1038/srep01046
Functional multiplex reporter assay using tagged Gaussia luciferase
Sjoerd van Rijn (2013)
10.1098/rsfs.2011.0037
Micro-ultrasound for preclinical imaging
F. Stuart Foster (2011)
10.1016/j.juro.2009.08.018
MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin.
Fanghong Chen (2009)
10.3322/canjclin.49.1.33
Global cancer statistics.
Donald Maxwell Parkin (1999)
Novel endoscopic diagnosis for bladder
SP Lerner (2015)
10.1007/s10439-011-0449-4
Biomedical Applications of Photoacoustic Imaging with Exogenous Contrast Agents
Geoffrey P. Luke (2011)
10.1177/1756287211431976
Best practice in the treatment of nonmuscle invasive bladder cancer
Anastasios Anastasiadis (2012)
10.1021/nn304347g
Gold nanorods for ovarian cancer detection with photoacoustic imaging and resection guidance via Raman imaging in living mice.
Jesse V Jokerst (2012)
10.1118/1.4764911
Speed-of-sound compensated photoacoustic tomography for accurate imaging.
Jithin Jose (2012)
10.2165/00019053-200321180-00003
The health economics of bladder cancer: a comprehensive review of the published literature.
Marc F Botteman (2003)
Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein.
William F. Benedict (2004)
10.1016/j.juro.2012.03.127
New optical imaging technologies for bladder cancer: considerations and perspectives.
Jen‐Jane Liu (2012)
10.1016/j.eururo.2006.01.017
Management of BCG failures in superficial bladder cancer: a review.
Johannes Alfred Witjes (2006)
10.1097/00002371-200403000-00005
Immunotherapy of Experimental Bladder Cancer with Recombinant BCG Expressing Interferon-&ggr;
Judith Arnold (2004)
10.1038/nmeth.1177
A secreted luciferase for ex vivo monitoring of in vivo processes
Tom Wurdinger (2008)
Real-time assessment of tissue hypoxia in vivo with combined photoacoustics and high-frequency ultrasound. Theranostics
M Gerling (2014)
10.1073/pnas.012611099
Optical imaging of Renilla luciferase reporter gene expression in living mice
Srabani Bhaumik (2001)
10.1111/cei.12315
Anti-interleukin-10R1 monoclonal antibody in combination with bacillus Calmette--Guérin is protective against bladder cancer metastasis in a murine orthotopic tumour model and demonstrates systemic specific anti-tumour immunity.
Mark R. Newton (2014)
10.1111/2049-632X.12186
In vivo imaging in an ABSL-3 regional biocontainment laboratory.
Charles A Scanga (2014)
10.1111/j.1751-1097.1997.tb03184.x
Visualizing gene expression in living mammals using a bioluminescent reporter.
Christopher H. Contag (1997)
10.1109/TUFFC.2013.2646
Development and initial application of a fully integrated photoacoustic micro-ultrasound system
Andrew Needles (2013)
10.7150/thno.7996
Real-Time Assessment of Tissue Hypoxia In Vivo with Combined Photoacoustics and High-Frequency Ultrasound
Marco Gerling (2014)
Global cancer statistics. CA Cancer J Clin
A Jemal (2011)
10.1117/1.3005421
Real-time in vivo photoacoustic and ultrasound imaging.
Roy G. M. Kolkman (2008)
10.1111/j.1464-410X.2009.08577.x
Mouse orthotopic models for bladder cancer research.
Eddie Y. Y. Chan (2009)
10.7497/j.issn.2095-3941.2012.04.007
A New Method of Establishing Orthotopic Bladder Transplantable Tumor in Mice
Xi-hua Yang (2012)
10.1111/J.1464-410X.2007.07165.X
A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.
Boris Hadaschik (2007)
Optimizing syngeneic orthotopic murine bladder cancer (MB49).
J H Günther (1999)
10.1038/NMETH.F.381
Screening and quantification of the tumor microenvironment with micro-ultrasound and photoacoustic imaging
Minalini Lakshman (2015)
10.1038/nrc1717
The multiple uses of fluorescent proteins to visualize cancer in vivo
Robert M Hoffman (2005)
10.1016/j.juro.2009.08.020
Optimizing orthotopic bladder tumor implantation in a syngeneic mouse model.
Eddie Y. Y. Chan (2009)
10.4137/CMO.S7658
Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model
Zhengwen Xiao (2011)
10.1002/ijc.2910510625
Human RT-4 bladder carcinoma is highly metastatic in nude mice and comparable to ras-H-transformed RT-4 when orthotopically onplanted as histologically intact tissue.
X Y Fu (1992)
10.1593/TLO.10187
Potential role of coregistered photoacoustic and ultrasound imaging in ovarian cancer detection and characterization.
Andres Aguirre (2011)
10.1158/0008-5472.CAN-05-0414
A new three-dimensional ultrasound microimaging technology for preclinical studies using a transgenic prostate cancer mouse model.
Lauren A. Wirtzfeld (2005)
10.1016/j.urology.2005.07.062
Bladder cancer: epidemiology, staging and grading, and diagnosis.
Ziya Kırkalı (2005)
10.1016/j.ymthe.2004.05.027
Intravesical Ad-IFNα causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-α protein
William F. Benedict (2004)
10.1016/j.eururo.2008.04.051
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.
Marko Babjuk (2008)
10.1111/J.1464-410X.2007.07193.X
Bioluminescence imaging to monitor bladder cancer cell adhesion in vivo: a new approach to optimize a syngeneic, orthotopic, murine bladder cancer model.
Andreas Jurczok (2008)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar